Disclosure Of Entity's Operating Segments [Text Block]

Xspray Pharma - Filing #702828

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—
Tax expense (income)	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—
Profit (loss) before tax	—	—	—	—	96 698 SEK	—	—	—	—	52 410 SEK	—	—
Profit (loss)	—	- SEK	- SEK	- SEK	96 698 SEK	96 698 SEK	52 410 SEK	- SEK	—	52 410 SEK	- SEK	- SEK
Assets	622 903 SEK	—	—	—	—	—	—	—	605 303 SEK	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	51 607 SEK	—	—	—	—	47 792 SEK	—	—
Cash flows from (used in) investing activities	—	—	—	—	105 818 SEK	—	—	—	—	96 828 SEK	—	—
Cash flows from (used in) financing activities	—	—	—	—	103 708 SEK	—	—	—	—	260 345 SEK	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]